CHRNA9 and type 1 diabetes mellitus: Importantly, our findings suggest epigenetic modification of GPM6A and CHRNA9, both involved in calcium channel activity and development, may play a role in the pathophysiology of CVD under conditions of higher glycemic exposure in type 1 diabetes.